Anthony E. Oro

Stanford University, Palo Alto, CA 
Oncology, Cell Biology, Biochemistry
"Anthony Oro"
Mean distance: (not calculated yet)


Sign in to add mentor
Ronald M. Evans grad student 1991 UCSD (Neurotree)
Matthew P. Scott post-doc 1998 Stanford Medical School


Sign in to add trainee
Erik G. Huntzicker grad student 2008 Stanford
Janet Y. Jin grad student 2008 Stanford
Marina Bershteyn grad student 2009 Stanford
Jordon K. Wang grad student 2009 Stanford
Ivette S. Estay grad student 2010 Stanford
Samantha Piekos grad student 2015-2020 Stanford
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kuonen F, Li NY, Haensel D, et al. (2021) c-FOS drives reversible basal to squamous cell carcinoma transition. Cell Reports. 37: 109774
Piekos SN, Gaddam S, Bhardwaj P, et al. (2021) Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes. Plos Computational Biology. 17: e1009382
Kilgour JM, Shah A, Urman NM, et al. (2021) Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Mirza AN, Gonzalez F, Ha SK, et al. (2020) The Sky's the LEMit: New insights into nuclear structure regulation of transcription factor activity. Current Opinion in Cell Biology. 68: 173-180
Yao CD, Haensel D, Gaddam S, et al. (2020) AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma. Nature Communications. 11: 5079
Haensel D, Oro AE. (2020) Starve a cold, and perhaps a cancer. Nature Cell Biology. 22: 755-757
Brown AS, Meera P, Quinones G, et al. (2019) Receptor protein tyrosine phosphatases control Purkinje neuron firing. Cell Cycle (Georgetown, Tex.). 1-7
Sohn GK, Kwon GP, Bailey-Healy I, et al. (2019) Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial. Jama Dermatology
Chiang A, Tan CZ, Kuonen F, et al. (2019) Genetic mutations underlying phenotypic plasticity in basosquamous carcinoma. The Journal of Investigative Dermatology
Kuonen F, Huskey NE, Shankar G, et al. (2019) Loss of primary cilia drives switching from Hedgehog to Ras/MAPK pathway in resistant basal cell carcinoma. The Journal of Investigative Dermatology
See more...